| Dr Jeffrey Edware Burtaine, MD | |
|
575 S. 9th Street, Suite 7, Lehighton, PA 18235 | |
| (570) 645-1000 | |
| (570) 645-1001 |
| Full Name | Dr Jeffrey Edware Burtaine |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine |
| Experience | 55 Years |
| Location | 575 S. 9th Street, Lehighton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083896302 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Hospital | 0648189688 | 94 |
| St. Luke's Hospital -monroe Campus | 1355637059 | 33 |
| The Carbon-schuylkill Community Hospital, Inc. | 4486562030 | 41 |
| St. Luke's Quakertown Hospital | 8224010350 | 13 |
| St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | The Carbon-schuylkill Community Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194891010 PECOS PAC ID: 4486562030 Enrollment ID: O20031117000015 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | St Luke's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740232719 PECOS PAC ID: 0648189688 Enrollment ID: O20040601000769 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | St. Luke's Quakertown Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225052616 PECOS PAC ID: 8224010350 Enrollment ID: O20040708000267 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | St Lukes Hospital-anderson Campus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376965731 PECOS PAC ID: 5799924114 Enrollment ID: O20141021000312 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | St. Luke's Hospital -monroe Campus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609311257 PECOS PAC ID: 1355637059 Enrollment ID: O20171221000156 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Entity Name | Gsl Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073256608 PECOS PAC ID: 8921338583 Enrollment ID: O20220719000789 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Edware Burtaine, MD 575 S. 9th Street, Suite 7, Lehighton, PA 18235 Ph: (570) 645-1000 | Dr Jeffrey Edware Burtaine, MD 575 S. 9th Street, Suite 7, Lehighton, PA 18235 Ph: (570) 645-1000 |
News Archive
The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients.
New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.
Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.
› Verified 8 days ago
Dimitry Belogorodsky, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2226 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 610-297-3003 | |
Dr. Peter J Baddick Iii, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2175 Blakeslee Boulevard Dr W, Lehighton, PA 18235 Phone: 570-386-4171 Fax: 570-386-2429 | |
Daniel George Walker, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2175 Blakeslee Boulevard Dr W, Lehighton, PA 18235 Phone: 570-386-4171 | |
David Thomas Ogurek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 N 1st St, Lehighton, PA 18235 Phone: 484-464-9510 | |
Kenneth R Sharp, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 N 1st St, Lehighton, PA 18235 Phone: 484-464-9510 Fax: 484-464-9515 | |
Ismat Ahmad, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 St Lukes Dr, Lehighton, PA 18235 Phone: 484-526-4500 | |
Dennis James Kondash, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 211 N 12th St, Lehighton, PA 18235 Phone: 610-377-7174 Fax: 610-377-4785 |